SOTAC logo

Sotac Pharmaceuticals Ltd

SOTAC·NSE·
90.05 +0.00 (+0.00%)
Market Cap99.51 Cr
PE Ratio17.25
Volume1,200
Day High - Low90.05 - 90.05
52W High-Low139.65 - 86.00
This price may be out of date. Last traded ₹90.05 on 20 Aug 2026 (13 days ago). Not a live price.
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
10.30%
Average
P/E
17.25x
Fair
Debt / Equity
0.64
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W86.00
139.65
DocStoX take

Supported by growth (8.5) and risk (6.4), but held back by momentum (0.0). Growth looks strong at 8.5, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.1
/10
Weak
Quality
Modest
ROE 10.3%
Valuation
Fair
P/E 17.3×
Growth
Strong
Revenue +15.6% 5Y CAGR
Risk
Moderate
D/E 0.64
Momentum
Weak
8% of 52-week range

At a glance

Market Cap
₹100 Cr
52W High / Low
₹140 / ₹86
Dividend Yield
0.11%
Promoter Holding
72.85%
EPS (TTM)
₹5.22
Book Value
₹53.30

Key highlights

  • Profit compounding 44% a year
  • Profitable in all of the last 5 years
  • Revenue compounding 16% a year
  • Momentum is weak (0.0/10)
  • Near the bottom of its 52-week range (8%)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Sotac Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.